Van Lanschot Kempen Investment Management’s Boston Scientific BSX Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.05M	Sell	94,918 -183,523	-66%	-$9.97M	0.03%	211
2026 Q1	$17.5M	Buy	278,441 +3,876	+1%	+$310K	0.15%	108
2025 Q4	$26.2M	Buy	274,565 +138,786	+102%	+$13.6M	0.22%	76
2025 Q3	$13.3M	Buy	135,779 +34,519	+34%	+$3.57M	0.12%	130
2025 Q2	$10.9M	Buy	+101,260	New	+$10.2M	0.1%	147

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Van Lanschot Kempen Investment Management's BSX Position: Q2 2026 in Review

Van Lanschot Kempen Investment Management reduced its Boston Scientific (BSX) stake by 66% in Q2 2026, selling an estimated $9.97M and leaving 94,918 shares worth $4.05M. The position accounts for 0.03% of the portfolio, ranked #211.

Van Lanschot Kempen Investment Management first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $26.2M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Van Lanschot Kempen Investment Management held 94,918 shares of Boston Scientific worth $4.05M as of Q2 2026.
Van Lanschot Kempen Investment Management sold 183,523 Boston Scientific shares in Q2 2026, an estimated $9.97M.
Boston Scientific made up 0.03% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #211 holding.
Van Lanschot Kempen Investment Management first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
Van Lanschot Kempen Investment Management's Boston Scientific position peaked at $26.2M in Q4 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.